Morgan Stanley’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Morgan Stanley’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$1.31K	–	7962
2023 Q3	$1.31K	Hold	1,000	–	–	﹤0.01%	7198
2023 Q2	$1.75K	Hold	1,000	–	–	﹤0.01%	7214
2023 Q1	$1.68K	Hold	1,000	–	–	﹤0.01%	7268
2022 Q4	$2.99K	Hold	1,000	–	–	﹤0.01%	7268
2022 Q3	$4K	Hold	1,000	–	–	﹤0.01%	7343
2022 Q2	$4K	Sell	1,000 -507	-34%	-$1.94K	﹤0.01%	7478
2022 Q1	$6K	Buy	+1,507	New	+$5.62K	﹤0.01%	7555
2021 Q3	–	Sell	-1,126	Closed	-$13K	–	8077
2021 Q2	$13K	Buy	+1,126	New	+$14.5K	﹤0.01%	7163

Morgan Stanley's MIRO Position: Q4 2023 in Review

Morgan Stanley sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 1,000 shares — an estimated $1.31K sold.

Morgan Stanley first reported a position in MIRO in Q2 2021 and held it in 8 quarters. The position peaked at $13K in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Morgan Stanley reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Morgan Stanley sold 1,000 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $1.31K.
Morgan Stanley first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Morgan Stanley's Miromatrix Medical Inc. Common Stock position peaked at $13K in Q2 2021.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.